BDMD – baird medical investment holdings ltd - ordinary share (US:NASDAQ)

News

Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com